Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Titel:
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Auteur:
Koren, Michael A Lin, Leyi Eckels, Kenneth H De La Barrera, Rafael Dussupt, Vincent Donofrio, Gina Sondergaard, Erica L Mills, Kristin T Robb, Merlin L Lee, Christine Adedeji, Oluwaseun Keiser, Paul B Curley, Justin M Copeland, Nathanial K Crowell, Trevor A Hutter, Jack N Hamer, Melinda J Valencia-Ruiz, Anais Darden, Janice Peel, Sheila Amare, Mihret F Mebrahtu, Tsedal Costanzo, Margaret Krebs, Shelly J Gromowski, Gregory D Jarman, Richard G Thomas, Stephen J Michael, Nelson L Modjarrad, Kayvon